Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02504021 · ClinicalTrials.gov registry record · NA
Family Meeting Study for End Stage Renal Disease
A NA study, sponsored by Mark A. Lumley.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT02504021 is a NA study that has completed, run by Mark A. Lumley. The registered enrollment target is 120 participants.
The verdict
NCT02504021, a NA study, has completed, sponsored by Mark A. Lumley.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.
Interventions
- BEHAVIORAL Family Consultation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02504021
The ClinicalTrials.gov registry entry for NCT02504021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mark A. Lumley, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Family Consultation is the first listed.
NCT02504021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02504021 about?
NCT02504021 is a clinical study titled "Family Meeting Study for End Stage Renal Disease". A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.
What is the current status of trial NCT02504021?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02504021?
The interventions under investigation include: Family Consultation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02504021?
This trial is sponsored by Mark A. Lumley, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.